Kuangli Bio-Tech Holdings Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	187.32	41.59	63.22	141.89	162.17	114.44
Short-Term Investments	-	-	9.19	-	-	-
Cash & Short-Term Investments	187.32	41.59	72.41	141.89	162.17	114.44
Cash Growth	138.10%	-42.57%	-48.97%	-12.51%	41.71%	-28.05%
Accounts Receivable	70.49	101.82	73.01	96.86	135.93	51.22
Other Receivables	0.39	2.01	0.28	1.84	85.76	1.55
Receivables	70.88	118.53	135.86	163.32	231.68	52.77
Inventory	52.53	64.24	52.13	63.65	98.87	9.59
Prepaid Expenses	-	2.69	2.79	9.78	9.55	3.03
Other Current Assets	119.82	22.16	42.52	21.16	20.85	-
Total Current Assets	430.55	249.2	305.7	399.79	523.13	179.82
Property, Plant & Equipment	408.78	319.86	380.64	361.44	368.49	22.06
Long-Term Investments	-	-	-	-	-	163.07
Goodwill	102.22	107.17	128.81	140.42	138.38	-
Other Intangible Assets	143.95	166	169.43	189.61	203.62	0.14
Long-Term Accounts Receivable	5.35	7.82	11.07	-	-	-
Long-Term Deferred Tax Assets	50.84	45.62	34.69	15.78	1.59	12.64
Other Long-Term Assets	7.37	14.54	12.93	8.52	13.9	0.26
Total Assets	1,149	910.2	1,043	1,116	1,249	377.99
Accounts Payable	47.64	56.53	22.35	29.66	95.15	32.03
Accrued Expenses	-	-	-	16.87	16.33	19.12
Short-Term Debt	112.29	134.34	147.37	148.42	147.7	-
Current Portion of Long-Term Debt	11.85	30.03	42.08	9.92	-	-
Current Portion of Leases	47.26	32.73	32.32	21.27	24.37	2.31
Current Income Taxes Payable	-	-	-	2.82	4.69	-
Current Unearned Revenue	25.22	16.69	10.8	12.7	12.83	0.07
Other Current Liabilities	33.16	37.63	28.18	31.01	27.13	2.79
Total Current Liabilities	277.41	307.95	283.11	272.66	328.19	56.32
Long-Term Debt	7.37	6.25	21.38	12.18	-	-
Long-Term Leases	251.69	133.47	178.37	157.97	176.27	5.24
Other Long-Term Liabilities	2.23	2.56	2.49	-	2.18	2.63
Total Liabilities	538.7	450.24	485.34	442.81	506.63	64.18
Common Stock	973.99	723.99	572.39	572.39	511.71	456.43
Additional Paid-In Capital	274.93	204.33	187.28	187.28	251.72	144.81
Retained Earnings	-577.01	-444.93	-272.14	-167.98	-243.23	-269.07
Comprehensive Income & Other	-61.55	-23.41	-42.91	-32.26	-37.92	-18.36
Total Common Equity	610.36	459.97	444.62	559.44	482.27	313.81
Minority Interest	-	-	-	-	260.2	-
Shareholders' Equity	610.36	459.97	557.92	672.74	742.47	313.81
Total Liabilities & Equity	1,149	910.2	1,043	1,116	1,249	377.99
Total Debt	430.45	336.82	421.52	349.75	348.33	7.55
Net Cash (Debt)	-243.13	-295.24	-349.11	-207.86	-186.15	106.89
Net Cash Growth	-	-	-	-	-	-30.76%
Net Cash Per Share	-2.80	-4.30	-6.10	-3.69	-3.67	2.34
Filing Date Shares Outstanding	97.4	72.4	57.24	57.24	51.17	45.64
Total Common Shares Outstanding	97.4	72.4	57.24	57.24	51.17	45.64
Working Capital	153.14	-58.75	22.59	127.13	194.94	123.51
Book Value Per Share	6.27	6.35	7.77	9.77	9.42	6.88
Tangible Book Value	364.19	186.8	146.38	229.41	140.28	313.67
Tangible Book Value Per Share	3.74	2.58	2.56	4.01	2.74	6.87
Land	-	-	-	-	-	2.45
Buildings	-	-	-	-	-	5.9
Machinery	115.16	119.75	116.21	75.91	127.91	223.35
Construction In Progress	-	-	-	129.26	42.28	-
Leasehold Improvements	133	138.89	135.01	24.91	54.63	48.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.